ZDHHC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.474000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.266800E-01
Normal-vs-Stage2
6.066600E-01
Normal-vs-Stage3
1.592440E-01
Normal-vs-Stage4
9.310800E-01
Stage1-vs-Stage2
9.280000E-01
Stage1-vs-Stage3
2.953800E-01
Stage1-vs-Stage4
6.924200E-01
Stage2-vs-Stage3
1.423010E-01
Stage2-vs-Stage4
6.429600E-01
Stage3-vs-Stage4
2.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.001200E-01
Normal-vs-AfricanAmerican
9.434200E-01
Normal-vs-Asian
7.150000E-01
Caucasian-vs-AfricanAmerican
2.763600E-01
Caucasian-vs-Asian
4.661000E-01
AfricanAmerican-vs-Asian
7.351800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.865600E-01
Normal-vs-Female
4.978600E-01
Male-vs-Female
7.274200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.772400E-01
Normal-vs-Age(41-60Yrs)
8.615800E-01
Normal-vs-Age(61-80Yrs)
4.368200E-01
Normal-vs-Age(81-100Yrs)
1.571360E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.332200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.428200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.005000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.228000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.828400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.946800E-01
Normal-vs-Daily Drinker
5.558000E-01
Normal-vs-Weekly Drinker
6.060200E-01
Normal-vs-Occasional Drinker
6.981400E-01
Normal-vs-Social Drinker
1.999780E-01
Non Drinker-vs-Daily Drinker
9.331200E-01
Non Drinker-vs-Weekly Drinker
7.173800E-01
Non Drinker-vs-Occasional Drinker
4.397400E-01
Non Drinker-vs-Social Drinker
7.876800E-01
Daily Drinker-vs-Weekly Drinker
7.962200E-01
Daily Drinker-vs-Occasional Drinker
5.335800E-01
Daily Drinker-vs-Social Drinker
7.470000E-01
Weekly Drinker-vs-Occasional Drinker
7.388400E-01
Weekly Drinker-vs-Social Drinker
5.247800E-01
Occasional Drinker-vs-Social Drinker
2.593400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.554300E-02
Normal-vs-Grade 2
1.655020E-03
Normal-vs-Grade 3
6.299800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.516500E-03
Grade 1-vs-Grade 3
2.447900E-02
Grade 1-vs-Grade 4
6.554300E-02
Grade 2-vs-Grade 3
8.997400E-01
Grade 2-vs-Grade 4
1.655020E-03
Grade 3-vs-Grade 4
6.299800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.713600E-01
Normal-vs-NonDiabetic
4.775400E-01
Diabetic-vs-NonDiabetic
6.170200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.600000E-01
Normal-vs-NoPancreatitis
4.064200E-01
Pancreatitis-vs-NoPancreatitis
1.482140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.170600E-01
Normal-vs-N1
5.941600E-01
N0-vs-N1
9.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.903200E-01
Normal-vs-TP53-NonMutant
4.761000E-01
TP53-Mutant-vs-TP53-NonMutant
1.099580E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
